205 related articles for article (PubMed ID: 34511598)
1. MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.
Singh SK; Kumar S; Viswakarma N; Principe DR; Das S; Sondarva G; Nair RS; Srivastava P; Sinha SC; Grippo PJ; Thatcher GRJ; Rana B; Rana A
Oncogene; 2021 Oct; 40(43):6153-6165. PubMed ID: 34511598
[TBL] [Abstract][Full Text] [Related]
2. Dichotomous role of the serine/threonine kinase MAP4K4 in pancreatic ductal adenocarcinoma onset and metastasis through control of AKT and ERK pathways.
Juin A; Spence HJ; Machesky LM
J Pathol; 2024 Apr; 262(4):454-466. PubMed ID: 38229581
[TBL] [Abstract][Full Text] [Related]
3. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
4. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
[TBL] [Abstract][Full Text] [Related]
5. Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.
Das S; Nair RS; Mishra R; Sondarva G; Viswakarma N; Abdelkarim H; Gaponenko V; Rana B; Rana A
Oncogene; 2019 May; 38(19):3569-3584. PubMed ID: 30664689
[TBL] [Abstract][Full Text] [Related]
6. Mixed Lineage Kinase 3 phosphorylates prolyl-isomerase PIN1 and potentiates GLI1 signaling in pancreatic cancer development.
Viswakarma N; Sondarva G; Principe DR; Nair RS; Kumar S; Singh SK; Das S; Sinha SC; Grippo PJ; Grimaldo S; Giulianotti PC; Rana B; Rana A
Cancer Lett; 2021 Sep; 515():1-13. PubMed ID: 34052323
[TBL] [Abstract][Full Text] [Related]
7. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
[TBL] [Abstract][Full Text] [Related]
8. Silencing SOX2 Expression by RNA Interference Inhibits Proliferation, Invasion and Metastasis, and Induces Apoptosis through MAP4K4/JNK Signaling Pathway in Human Laryngeal Cancer TU212 Cells.
Yang N; Wang Y; Hui L; Li X; Jiang X
J Histochem Cytochem; 2015 Sep; 63(9):721-33. PubMed ID: 26001828
[TBL] [Abstract][Full Text] [Related]
9. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
10. MAP4K4 Is a Threonine Kinase That Phosphorylates FARP1.
Schwaid AG; Su C; Loos P; Wu J; Nguyen C; Stone KL; Kanyo J; Geoghegan KF; Bhattacharya SK; Dow RL; Buckbinder L; Carpino PA
ACS Chem Biol; 2015 Dec; 10(12):2667-71. PubMed ID: 26422651
[TBL] [Abstract][Full Text] [Related]
11. MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Fuller SJ; Edmunds NS; McGuffin LJ; Hardyman MA; Cull JJ; Alharbi HO; Meijles DN; Sugden PH; Clerk A
Biochem J; 2021 Jun; 478(11):2121-2143. PubMed ID: 34032269
[TBL] [Abstract][Full Text] [Related]
12. MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage.
Chen K; Yuan X; Wang S; Zheng F; Fu Z; Shen Z; Cheng X; Wang Y; Tang S; Ni H; Wang F; Lu G; Wu Y; Xia D; Lu W
Oncogene; 2023 May; 42(18):1438-1452. PubMed ID: 36922678
[TBL] [Abstract][Full Text] [Related]
13. Silencing of MAP4K4 by short hairpin RNA suppresses proliferation, induces G1 cell cycle arrest and induces apoptosis in gastric cancer cells.
Liu YF; Qu GQ; Lu YM; Kong WM; Liu Y; Chen WX; Liao XH
Mol Med Rep; 2016 Jan; 13(1):41-8. PubMed ID: 26549737
[TBL] [Abstract][Full Text] [Related]
14. Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity.
Kumar S; Singh SK; Viswakarma N; Sondarva G; Nair RS; Sethupathi P; Sinha SC; Emmadi R; Hoskins K; Danciu O; Thatcher GRJ; Rana B; Rana A
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7961-7970. PubMed ID: 32209667
[TBL] [Abstract][Full Text] [Related]
15. MAP4K4 and cancer: ready for the main stage?
González-Montero J; Rojas CI; Burotto M
Front Oncol; 2023; 13():1162835. PubMed ID: 37223681
[TBL] [Abstract][Full Text] [Related]
16. Histone lactylation-derived LINC01127 promotes the self-renewal of glioblastoma stem cells via the cis-regulating the MAP4K4 to activate JNK pathway.
Li L; Li Z; Meng X; Wang X; Song D; Liu Y; Xu T; Qin J; Sun N; Tian K; Zhong J; Yu D; Song Y; Hou T; Jiang C; Chen Q; Cai J
Cancer Lett; 2023 Nov; 579():216467. PubMed ID: 38084701
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-200c suppressed cervical cancer cell metastasis and growth via targeting MAP4K4.
Mei J; Wang DH; Wang LL; Chen Q; Pan LL; Xia L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):623-631. PubMed ID: 29461619
[TBL] [Abstract][Full Text] [Related]
18. Mixed lineage kinase 3 modulates β-catenin signaling in cancer cells.
Thylur RP; Senthivinayagam S; Campbell EM; Rangasamy V; Thorenoor N; Sondarva G; Mehrotra S; Mishra P; Zook E; Le PT; Rana A; Rana B
J Biol Chem; 2011 Oct; 286(43):37470-82. PubMed ID: 21880738
[TBL] [Abstract][Full Text] [Related]
19. The role of mixed lineage kinase 3 (MLK3) in cancers.
Ramachandraiah K; Thylur Puttalingaiah R
Pharmacol Ther; 2022 Oct; 238():108269. PubMed ID: 36038020
[TBL] [Abstract][Full Text] [Related]
20. MAP4K4 regulates integrin-FERM binding to control endothelial cell motility.
Vitorino P; Yeung S; Crow A; Bakke J; Smyczek T; West K; McNamara E; Eastham-Anderson J; Gould S; Harris SF; Ndubaku C; Ye W
Nature; 2015 Mar; 519(7544):425-30. PubMed ID: 25799996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
